BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 23023713)

  • 21. Premalignant cell dynamics in indolent B-cell malignancies.
    Milpied P; Nadel B; Roulland S
    Curr Opin Hematol; 2015 Jul; 22(4):388-96. PubMed ID: 26049761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment and comprehensive analysis of a new human transformed follicular lymphoma B cell line, Tat-1.
    Denyssevych T; Lestou VS; Knesevich S; Robichaud M; Salski C; Tan R; Gascoyne RD; Horsman DE; Mayer LD
    Leukemia; 2002 Feb; 16(2):276-83. PubMed ID: 11840295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular and clinical progress in follicular lymphoma lacking the t(14;18) translocation (Review).
    Zhu Z; Li T; Zhang X; Zhang Z; Zhu D; Lin P; Tu S; Ren W
    Int J Oncol; 2020 Jan; 56(1):7-17. PubMed ID: 31789408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is t(14;18)(q32;q21) a constant finding in follicular lymphoma? An interphase FISH study on 63 patients.
    Godon A; Moreau A; Talmant P; Baranger-Papot L; Geneviève F; Milpied N; Zandecki M; Avet-Loiseau H
    Leukemia; 2003 Jan; 17(1):255-9. PubMed ID: 12529690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bcl-6 p53 mutations in lymphomas carrying the bcl-2/Jh rearrangement.
    Bellido M; Capello D; Altés A; Estivill C; Gaidano G; Pujol R; Bordes R; Baiget M; Saglio G; Sierra J; Nomdedéu JF
    Haematologica; 2002 Sep; 87(9):908-17. PubMed ID: 12217802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma.
    Correia C; Schneider PA; Dai H; Dogan A; Maurer MJ; Church AK; Novak AJ; Feldman AL; Wu X; Ding H; Meng XW; Cerhan JR; Slager SL; Macon WR; Habermann TM; Karp JE; Gore SD; Kay NE; Jelinek DF; Witzig TE; Nowakowski GS; Kaufmann SH
    Blood; 2015 Jan; 125(4):658-67. PubMed ID: 25452615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Follicular lymphoma lacking the t(14;18)(q32;q21): identification of two disease subtypes.
    Horsman DE; Okamoto I; Ludkovski O; Le N; Harder L; Gesk S; Siebert R; Chhanabhai M; Sehn L; Connors JM; Gascoyne RD
    Br J Haematol; 2003 Feb; 120(3):424-33. PubMed ID: 12580956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of the SOX5 gene as a novel IGH-involved translocation partner in BCL2-negative follicular lymphoma with t(12;14)(p12.2;q32).
    Shiseki M; Masuda A; Yoshinaga K; Mori N; Okada M; Motoji T; Tanaka J
    Int J Hematol; 2015 Nov; 102(5):633-8. PubMed ID: 26115875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pitfalls and update in Haematopathology. Case 1. Follicular lymphoma grade 1-2 according to the WHO classification 2008, "pseudo BCL2 negative" with low and heterogeneous expression of the CD10].
    Copie-Bergman C
    Ann Pathol; 2012 Oct; 32(5):331-5. PubMed ID: 23141940
    [No Abstract]   [Full Text] [Related]  

  • 30. Molecular detection of t(14;18)(q32;q21) in follicular lymphoma.
    Yin CC; Luthra R
    Methods Mol Biol; 2013; 999():203-9. PubMed ID: 23666699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cryptic IGH/BCL2 rearrangements with variant FISH patterns in follicular lymphoma.
    Baró C; Espinet B; Salido M; García M; Sánchez B; Florensa L; Bellosillo B; Serrano S; Solé F
    Leuk Res; 2011 Feb; 35(2):256-9. PubMed ID: 20952062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
    Papajík T; Jedlicková K; Kriegová E; Jarosová M; Raida L; Faber E; Hubácek J; Vondráková J; Pikalová Z; Indrák K
    Neoplasma; 2001; 48(6):501-5. PubMed ID: 11949845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human t(14;18)positive germinal center B cells: a new step in follicular lymphoma pathogenesis?
    Tellier J; Menard C; Roulland S; Martin N; Monvoisin C; Chasson L; Nadel B; Gaulard P; Schiff C; Tarte K
    Blood; 2014 May; 123(22):3462-5. PubMed ID: 24677543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Follicular lymphoma with a novel t(14;18) breakpoint involving the immunoglobulin heavy chain switch mu region indicates an origin from germinal center B cells.
    Fenton JA; Vaandrager JW; Aarts WM; Bende RJ; Heering K; van Dijk M; Morgan G; van Noesel CJ; Schuuring E; Kluin PM
    Blood; 2002 Jan; 99(2):716-8. PubMed ID: 11781262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Molecular heterogeneity of follicular lymphomas and its clinical implications].
    Karube K; Ohshima K
    Rinsho Ketsueki; 2011 Apr; 52(4):198-203. PubMed ID: 21566405
    [No Abstract]   [Full Text] [Related]  

  • 36. Lack of Bcl-2 expression in follicular lymphoma may be caused by mutations in the BCL2 gene or by absence of the t(14;18) translocation.
    Schraders M; de Jong D; Kluin P; Groenen P; van Krieken H
    J Pathol; 2005 Feb; 205(3):329-35. PubMed ID: 15682435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acquisition of a t(11;14)(q13;q32) in clonal evolution in a follicular lymphoma with a t(14;18)(q32;q21) and t(3;22)(q27;q11.2).
    Koduru PR; Chen W; Garcia R; Fuda F
    Cancer Genet; 2015 Jun; 208(6):303-9. PubMed ID: 25953460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unusual deletions in the immunoglobulin heavy chain locus in follicular B-cell lymphoma with t(14;18)(q32.3;q21.3).
    Dyer MJ
    Genes Chromosomes Cancer; 1993 Dec; 8(4):270-2. PubMed ID: 7512371
    [No Abstract]   [Full Text] [Related]  

  • 39. [BCL-2 in primary central nervous system lymphomas. Immunohistochemistry and molecular biology].
    Buccoliero AM; Castiglione F; Caldarella A; Rossi Degl'Innocenti D; Taddei A; Ammannati F; Mennonna P; Taddei GL
    Pathologica; 2004 Oct; 96(5):425-9. PubMed ID: 15688978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneous breakpoints on the immunoglobulin genes are involved in fusion with the 5' region of BCL2 in B-cell tumors.
    Yonetani N; Ueda C; Akasaka T; Nishikori M; Uchiyama T; Ohno H
    Jpn J Cancer Res; 2001 Sep; 92(9):933-40. PubMed ID: 11572760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.